ZBTB8B Activators
Chemical activators of ZBTB8B work through various signaling pathways to modulate the phosphorylation state and activity of the protein. Forskolin, by directly activating adenylate cyclase, raises intracellular cAMP levels, which in turn activate protein kinase A (PKA). The activated PKA can phosphorylate ZBTB8B, leading to its activation. Similarly, isoproterenol, a beta-adrenergic agonist, also increases cAMP through adenylyl cyclase activation with the same potential effect on PKA and ZBTB8B. The cAMP analogs, Dibutyryl-cAMP and 8-Bromo-cAMP, permeate cells and activate PKA, which may phosphorylate and activate ZBTB8B as well. On a different pathway, Ionomycin increases intracellular calcium levels, which activate the calmodulin-dependent kinase (CaMK). Upon activation, CaMK may target ZBTB8B for phosphorylation.
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can subsequently phosphorylate ZBTB8B if it is recognized as a substrate. Epidermal Growth Factor (EGF) triggers its receptor, starting a cascade that involves the MAPK/ERK pathway, potentially leading to the activation of ZBTB8B if it lies downstream of this signaling route. Anisomycin activates the JNK/SAPK pathway, which can lead to the phosphorylation of several transcription factors and possibly ZBTB8B. Insulin, through its receptor, initiates a series of phosphorylation events via the PI3K/Akt pathway which may also culminate in the phosphorylation of ZBTB8B. Finally, both Calyculin A and Okadaic Acid inhibit protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased phosphorylation levels within the cell and potentially maintaining ZBTB8B in an activated state by preventing its dephosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. This can activate calmodulin-dependent kinase (CaMK), which might phosphorylate and thereby activate ZBTB8B, particularly if ZBTB8B has regulatory sites accessible to CaMK. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins. Activation of PKC can lead to the phosphorylation and activation of ZBTB8B if it is a substrate for PKC. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels by activating adenylyl cyclase through the beta-adrenergic receptor, potentially leading to the activation of PKA and subsequent phosphorylation and activation of ZBTB8B. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is an activator of the JNK/SAPK signaling pathway, which can lead to the phosphorylation and activation of transcription factors and possibly ZBTB8B if it is a part of this signaling pathway. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, leading to a cascade of phosphorylation events via the PI3K/Akt pathway, which can lead to the phosphorylation and activation of various proteins, potentially including ZBTB8B if it is a downstream effector. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which can result in increased phosphorylation levels of cellular proteins. This could lead to the maintained phosphorylation and activation of ZBTB8B by preventing its dephosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of PP1 and PP2A, similar to Calyculin A, leading to increased phosphorylation of proteins. This mechanism could keep ZBTB8B in a phosphorylated and activated state. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that can activate PKA. PKA then can phosphorylate target proteins, possibly leading to the activation of ZBTB8B if it is subject to regulation by PKA-mediated phosphorylation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is another cell-permeable analog of cAMP that activates PKA. Activation of PKA could in turn phosphorylate and activate ZBTB8B, assuming ZBTB8B is a PKA substrate. | ||||||